The latest trading day saw Pfizer (PFE) settling at $25.60, representing a -0.43% change from its previous close.

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Sponsored by the Indian Council of Social Science Research (ICSSR), the seminar served as a platform for experts, researchers, and students to discuss the role of artificial intelligence (AI) in ...

Núñez Feijóo, the leader of the Spanish People's Party (Partido Popular/EPP), the main opposition force in Parliament, met with Sánchez (PSOE/S&D) for talks on how the government intends to reach its ...

A 400-home neighbourhood at Hazelhurst Farm in Worsley, a site allocated in Greater Manchester’s Places for Everyone development plan, will go to committee for a decision next week.

This article has been corrected to reflect that the senators asked UpScriptHealth to respond. In August 2024, Pfizer Inc ...

In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla, Ph.D., received a 14% total ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Pfizer has terminated a Phase I trial of its investigational STING therapy in advanced solid tumors, according to an update ...

Knight-Swift Transportation Holdings Inc. (NYSE: KNX) (the "Company" or "Knight-Swift") announced today that Douglas Col has joined Knight-Swift's Board of Directors (the "Board") effective March 13, ...

Passat brake pedal felt soft and went to the floor in July 2024. My shop determined air was in the lines and bled the brakes. The problem ...